DF9001

Trinket immunotherapy for EGFR expressing solid tumors. (EGFR expression confirmed centrally by Dragonfly Therapeutics)
Status:

Open

Trial Type:
Early Phase Trials for Multiple Cancer Types

Contact:

Dr. Howard Safran
hsafran@lifespan.org

©2023 Brown Cancer Clinical Trials